Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 27Mesothelioma, Malignant 14Solid Tumors 11Mesothelioma 10Advanced Solid Tumor 8Solid Tumor 5Advanced Solid Tumors 4Carcinoma, Non-Small-Cell Lung 3Solitary Fibrous Tumor, Pleural 2Uterine Cervical Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Penile Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Metastatic Solid Tumors 1Malignant Neoplasmas 1Lung Neoplasms 1Locally Advanced or Metastatic Solid Tumours 1Cholangiocarcinoma of the Gallbladder 1Advanced Solid Tumours 1Advanced Solid Tumour 1Advanced Cancer 1Advance Solid Tumors 1Adult Solid Tumor 1

Interventions

Injections 27Carboplatin 18Docetaxel 14pembrolizumab 13Paclitaxel 12Bevacizumab 10durvalumab 8Nivolumab 8Cisplatin 8Fluorouracil 7Pemetrexed 6Oxaliplatin 6Leucovorin 6trifluridine tipiracil drug combination 5toripalimab 5tislelizumab 5linifanib 5Capecitabine 5zimberelimab 4talazoparib 4olaparib 4fludarabine 4Panobinostat 4Itraconazole 4Irinotecan 4Gemcitabine 4Everolimus 4tremelimumab 3sotorasib 3sintilimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Advanced Solid Tumors × Gemcitabine × Other solid neoplasm × Clear all
NCT03034304 2025-07-24

A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors

HRYZ Biotech Co.

Phase 1 Terminated
105 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT03577704 2023-04-12

HLX07Ib/II

Shanghai Henlius Biotech

Phase 1/2 Completed
56 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT04481009 2022-12-12

A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors

Eucure (Beijing) Biopharma Co., Ltd

Phase 1/2 Completed
26 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01063816 2021-08-02

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

AbbVie

Phase 1 Completed
79 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡